100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Contract Awards
Delivery Order HHSO100201200015I-HHSO10033005T
Award Date
5/30/13
Potential Completion Date
8/31/15
Potential Value
Not listed
Overview
Contacts
Activity
2
Transactions
2
Subawards
Opportunity Stack
Similar Awards
Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Awardee
Sanofi Vaccines US Inc. NCXBGGQ8YTU9
Ultimate Awardee
Not listed
NAICS Category
325414 - Biological Product (except Diagnostic) Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pandemic Influenza Preparedness and Response 2012-2016
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Swiftwater, PA 18370, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Pandemic Influenza Preparedness and Response 2012-2016
Master IDIQ
HHSO100201200015I
Indefinite Delivery Contract
HHSO100201200015I-HHSO10033005T
Delivery Order
Update #1
Update #2
Update #3
Update #4
ASPR-13-06569 -- SP-CLIN 0003 CGMP INFLUENZA VACCINE CLINICAL LOT UNDER CONTRACT HHSO100201200015I
Posted 5/30/13
5
1
Name
Description
Solicitation Number
FederalAgency
Type
PostedDate
Acquisition of MCMs for Pandemic Influenza Preparedness and Response
Added: Jan 31, 2012 11:24 am THIS IS A PRESOLICITATION NOTICE ONLY.Human influenza pandemics continue to be a public health concern. Four human influenza pandemics have occurred in the past century. BARDA has recently completed the preparation and response to the 2009 H1N1 pandemic influenza virus. The WHO estimates approximately 59% case fatality of the currently circulating H5N1 avian influenza virus. At this time it is uncertain which influenza virus variant will cause the next pandemic. The BARDA Strategic Plan 2011-2016 outlines the approach to enhance national MCM preparedness and response. BARDA plans to continue the programs for the development and procurement of MCM for pandemic influenza preparedness and response. To accomplish this goal, BARDA intends to publish a Request for Proposals for the supply of the following items and/or services: pre-pandemic master/working virus seeds; pre-pandemic and pandemic pilot, clinical and commercial bulk vaccines and adjuvants; storage and stability studies of vaccines and adjuvants; formulation-fill-finish of vaccine and adjuvants; preclinical and clinical studies with pre-pandemic and pandemic vaccine; international shipping; storage services and stability program for vaccine and adjuvants, (bulk and final containers) from current contracts when applicable; and disposal of vaccine bulk and final containers. The Department of Health and Human Services tough the Biomedical Advanced Research and Development Authority (BARDA) contemplates single or multiple awards of contracts to companies that meet the following mandatory criteria: The offeror shall produce vaccines against influenza and influenza strains with pandemic potential; shall demonstrate a successful experience in the manufacturing of influenza vaccine by: • Holding a US influenza vaccine license OR • Have developed an influenza vaccine as evidenced by: o A complete final Phase 3 clinical study report AND o A documented BLA in preparation. The anticipated period of performance will be for a total of up to five (5) years or sixty (60) months with a potential for two (2) one (1) year option periods. Additional details and requirements will be described in the solicitation. A Request for Proposal (RFP) will be available electronically tough the Federal Business Opportunities (FedBizOpps) website (www.fbo.gov) on or about February 14, 2012, with proposals being due on or about April 2, 2012.Any responsible offeror may submit a proposal that will be considered by the Government. This notice does not commit the Government to the award of a contract. It is the offeror's responsibility to monitor this website (www.fbo.gov) for the release of the solicitation as well as any amendments to the solicitation. Potential offerors will be responsible for downloading their own copy of the solicitation and any amendments via this website. No collect calls will be accepted. No facsimile transmissions will be accepted. All responses and/or inquiries concerning this requirement MUST be identified with the RFP number, name of firm, name of requestor, mailing address, telephone number, fax number, email address and should be submitted to the primary and/or secondary point of contact identified in this notice.Multiple awards may result from this solicitation with an estimated award date of August 2012.
11-100-SOL-00020
Department of Health and Human Services Immediate Office of the Secretary
Award Notice 1/1
1/31/12, 11:24 AM
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
1
ASPR-13-06569 -- SP-CLIN 0003 CGMP INFLUENZA VACCINE CLINICAL LOT UNDER CONTRACT HHSO100201200015I
Funding Only Action
($2m)
6/23/13
Not listed
ASPR-13-06569 -- SP-CLIN 0003 CGMP INFLUENZA VACCINE CLINICAL LOT UNDER CONTRACT HHSO100201200015I
Not listed
$1.9m
5/30/13